|
Pfizer Announces EMA Acceptance of Regulatory Submissions
|
22 August 2011 |
|
Pfizer Wins Viagra Patent Trial
|
15 August 2011 |
|
NCCN Receives $2M Educational Grant from Pfizer
|
04 August 2011 |
|
Pfizer Reports Second-Quarter 2011 Results
|
02 August 2011 |
|
Pfizer To Acquire Icagen
|
21 July 2011 |
|
Pfizer to Explore Strategic Alternatives for its Animal Health and Nutrition Businesses
|
08 July 2011 |
|
Pfizer and ChemRar to Explore Innovative Medical Research and Development Partnership in Russia
|
01 July 2011 |
|
Pfizer Files with the FDA for Review of Axitinib for Patients with Advanced Renal Cell Carcinoma
|
29 June 2011 |
|
Pfizer Conducts First "Virtual" Clinical Trial Allowing Patients to Participate Regardless of Geography
|
08 June 2011 |
|
Pfizer and Hisun Sign MOU to Establish a Joint Venture
|
03 June 2011 |
|
Pfizer Announces New Strategic Partnerships with ICON and PAREXEL International Corporation
|
27 May 2011 |
|
SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
|
21 May 2011 |
|
Pfizer To Present New Research From Fifteen Compounds
|
17 May 2011 |
|
Pfizer Reports First-Quarter 2011 Results
|
04 May 2011 |
|
Pfizer Announces Top-Line Results of Final Two Pivotal Phase 3 Trials of Tofacitinib (CP-690,550)
|
29 April 2011 |
|
Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005
|
27 April 2011 |
|
Pfizer Announces Top-Line Results of Third Phase 3 Clinical Trial of Tofacitinib (CP-690,550)
|
18 April 2011 |
|
Pfizer and Medivation Announce Results from Phase 3 HORIZON Trial of Dimebon in Huntington Disease
|
12 April 2011 |
|
Pfizer to Sell Capsugel to KKR
|
05 April 2011 |
|
Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010
|
01 April 2011 |